PRESS RELEASE published on 05/11/2023 at 09:51, 3 years ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S Management Board proposes the distribution of a dividend of € 0.40 per share for the financial year 2022/23
PRESS RELEASE published on 03/16/2023 at 14:33, 3 years 2 months ago AT&S Austria Technologie & Systemtechnik AG: AT&S already positions itself for the financial year 2026/27
PRESS RELEASE published on 03/07/2023 at 17:30, 3 years 2 months ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S adjusts growth pace to current market conditions and postpones medium-term targets by one year to financial year 2026/27
PRESS RELEASE published on 02/02/2023 at 06:59, 3 years 3 months ago AT&S Austria Technologie & Systemtechnik AG: AT&S well prepared for challenging market environment
PRESS RELEASE published on 02/01/2023 at 15:56, 3 years 3 months ago EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S revises outlook for the current financial year 2022/23
Published on 05/23/2026 at 03:15, 8 hours 46 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 9 hours 1 minute ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 9 hours 36 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 9 hours 36 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 11 hours 1 minute ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/22/2026 at 22:05, 13 hours 56 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 13 hours 56 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 16 hours 10 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 17 hours 28 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 17 hours 31 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 16 hours 26 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 17 hours 56 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 17 hours 56 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 23 hours 9 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 23 hours 9 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
